Copy Link Print Information

Pasritamig

(Synonyms: JNJ-78278343; KLCB-245)
Revisión del cliente

Based on 1 Customer Validation

Pasritamig (JNJ-78278343; KLCB-245) is a bispecific T-cell engager (BiTE) targeting the human kallikrein KLK2 and CD3 receptor complex. Pasritamig directs T-cell cytotoxicity toward KLK2-expressing tumor cells and induces T cell-mediated lysis of KLK2-expressing prostate cancer cells. Pasritamig can be used in research on metastatic castration-resistant prostate cancer.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.97%
  • No. CAS: 2921676-04-0
  • Peso molecular:124.81 kDa
  • Almacenamiento:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Pasritamig
  • Experimental Validation Results for Pasritamig
  • Experimental Validation Results for Pasritamig
  • Experimental Validation Results for Pasritamig
  • Pasritamig Chemical Structure
    Pasritamig Chemical Structure
No. CAS: 2921676-04-0
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Pasritamig Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Ver todos los productos específicos de isoformas Kallikrein

More

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    G1-kappa_scFv-h-CH2-CH3

  • 1/16

    Immobilized Kallikrein-2 Protein, Human (HEK293, His, HY-P70317) can bind Pasritamig. The EC50 for this effect is 53.53 ng/mL.

  • 1/16

    Immobilized CD3 epsilon Protein, Human (HEK293, His,HY-P70506) can bind Pasritamig. The EC50 for this effect is 791.3 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 Juakat cells with Pasritamig (HY-P991015, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Pasritamig Chemical Structure
    1/16
  • Pasritamig
  • Immobilized Kallikrein-2 Protein, Human (HEK293, His, HY-P70317) can bind Pasritamig. The EC50 for this effect is 53.53 ng/mL.
  • Immobilized CD3 epsilon Protein, Human (HEK293, His,HY-P70506) can bind Pasritamig. The EC50 for this effect is 791.3 ng/mL.
  • Flow cytometric analysis of 1X106 Juakat cells with Pasritamig (HY-P991015, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • G1-kappa_scFv-h-CH2-CH3